Salesforce (CRM) had a monster Monday. The stock jumped 10.1%, leaving the Nasdaq's 0.5% gain and the S&P 500's 0.1% rise in the dust. Even the Technology sector's 2.3% advance looked modest by comparison. So what lit the fuse?
A big part of the story is artificial intelligence. NVIDIA (NVDA) rolled out new AI tools for autonomous driving, humanoid robots, and AI factories, which stoked optimism across the software space. Salesforce, with its growing AI ambitions, rode that wave.
But there's also a company-specific catalyst: Bloomberg reported Monday that Salesforce's investment in the AI startup Anthropic is now worth about $5 billion. That's a nice paper gain and a reminder that Salesforce isn't just selling customer relationship management software anymore—it's betting big on AI.
Salesforce To Invest $2 Billion In France
Separately, Salesforce announced a $2 billion investment in France through 2030. The plan includes a new AI Innovation Hub in Paris, workforce training, and expanded data sovereignty initiatives. Paris will host the company's first European Union AI Innovation Hub, focused on AI development and customer collaboration.
Salesforce also plans to hire in cybersecurity, data, agentic AI, and deployment engineering. And it's putting money where its mouth is: more than $2.6 million in grants for French nonprofits and an Agentic Academy with the Simplon Foundation to train at least 2,000 people in AI skills.
The company highlighted growing adoption of its Agentforce platform among French organizations like Bouygues, Laboratoires Pierre Fabre, and Adecco Group. France is one of Salesforce's largest European markets, so this investment is as much about deepening roots as it is about AI.
Is The Stock Finally Reversing Long-Term Downtrend?
From a technical perspective, the rally is impressive but incomplete. Salesforce now trades 17.3% above its 20-day moving average and 16.1% above its 50-day moving average—clear signs of strong short-term momentum.
But the 200-day moving average tells a different story. The stock is still 5.1% below that level, meaning the broader downtrend hasn't been fully reversed. The moving averages themselves are in a bearish alignment: the 20-day is below the 50-day, and the 50-day is below the 200-day. That's the classic pattern of a downtrend that's still healing.
Over the past 12 months, Salesforce is down 19.8%, so Monday's rally is a welcome relief but not a cure-all. The MACD indicator, however, is looking more encouraging: it's above its signal line with a positive histogram, suggesting buyers are gaining control and downside pressure is easing.
Technically, the next big resistance level is around $251, where traders might be tempted to take profits. On the downside, support sits near $170.50, a level that has attracted buyers before and could act as a floor if the rally fades.
Analyst Consensus & Recent Actions
Wall Street is cautiously optimistic. The stock carries a Buy rating with an average price target of $245.59. But recent analyst moves show some hesitation:
- Citigroup: Neutral (Lowers forecast to $187.00) on May 28
- Canaccord Genuity: Buy (Lowers forecast to $225.00) on May 28
- Bernstein: Underperform (Lowers forecast to $173.00) on May 28
All three lowered their targets on the same day, which suggests a coordinated reassessment after earnings or guidance. The wide range of targets—from $173 to $225—shows just how divided the Street is on Salesforce's near-term prospects.
The Funds Most Invested In Salesforce
Salesforce is a heavyweight in several ETFs, which means fund flows can move the stock. Here are the funds with the largest exposure:
- SmartETFs Advertising and Marketing Technology ETF (MRAD): 4.11% Weight
- iShares Expanded Tech-Software Sector ETF (IGV): 6.68% Weight
- First Trust DJ Internet Index Fund (FDN): 4.07% Weight
Because CRM carries significant weight in these funds, any big inflows or outflows will force automatic buying or selling of the stock. So keep an eye on ETF flows as a potential tailwind or headwind.
CRM Stock Price Activity: Salesforce shares were up 10.11% at $210.42 at the time of publication on Monday.